Squarepoint
GH icon

Squarepoint’s Guardant Health GH Stock Holding History

Squarepoint’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,800
Closed -$2.12M – 4516
2025
Q4 		$2.12M Sell
20,800
-400
-2% -$35.8K ﹤0.01% 2018
2025
Q3 		$1.32M Buy
21,200
+17,300
+444% +$941K ﹤0.01% 2435
2025
Q2 		$203K Sell
3,900
-3,100
-44% -$138K ﹤0.01% 3973
2025
Q1 		$298K Sell
7,000
-32,000
-82% -$1.38M ﹤0.01% 3736
2024
Q4 		$1.19M Buy
+39,000
New +$1.1M ﹤0.01% 2890
2024
Q3 		– Sell
-20,600
Closed -$595K – 4309
2024
Q2 		$595K Sell
20,600
-11,500
-36% -$268K ﹤0.01% 2947
2024
Q1 		$662K Buy
+32,100
New +$688K ﹤0.01% 2862
2021
Q3 		– Sell
-5,100
Closed -$633K – 3091
2021
Q2 		$633K Hold
5,100
– – ﹤0.01% 1967
2021
Q1 		$779K Buy
+5,100
New +$771K ﹤0.01% 1709

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's GH Position: Q1 2026 in Review

Squarepoint increased its Guardant Health (GH) stake by 40% in Q1 2026, buying an estimated $5.51M and bringing the position to 191,740 shares worth $17.7M. The position accounts for 0.02% of the portfolio, ranked #776.

Squarepoint first reported a position in GH in Q2 2019 and has held it in 17 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Squarepoint held 191,740 shares of Guardant Health worth $17.7M as of Q1 2026.
  • Squarepoint bought 54,846 Guardant Health shares in Q1 2026, an estimated $5.51M.
  • Guardant Health made up 0.02% of Squarepoint's portfolio in Q1 2026, its #776 holding.
  • Squarepoint first reported a position in Guardant Health in Q2 2019 and has held it in 17 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.